ReviewInternational journal of molecular sciences2021

Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.

Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.